A PHASE 2B RANDOMIZED STUDY OF SINGLE AGENT SELINEXOR IN PATIENTS WITH RELAPSED/REFRACTORY DIFFUSE LARGE B‐CELL LYMPHOMA (DLBCL). (June 2017)

• Record Type: Journal Article
• Authors: Casasnovas, R.; Westin, J.; Thieblemont, C.; Zijlstra, J.; Hill, B.; De La Cruz Vicente, F.; Choquet, S.; Caimi, P.; Kaplan, J.; Canales, M.; Kuruvilla, J.; Follows, G.; van den Neste, E.; Meade, J.; Wrigley, B.; Devlin, M.; Saint‐Martin, J.; Nippgen, C.; Gardner, H.; Shacham, S.; Kauffman, M.; Maerevoet, M.
• Is Part Of: Hematological oncology. Volume 35(2017)Supplement 2
• Page Start: 191
• Page End: 192
• Publication Date: 2017-06
• Subjects: Hematological oncology -- Periodicals; Hematology; Medical Oncology; 616.99418005
• DOI: 10.1002/hon.2438_53
• Languages: English
• ISSNs: 0278-0232